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ABSTRACT 
The vitamin D role on the immune response of systemic lupus erythematosus (SLE) patient is 
mediated by vitamin D receptor (VDR). Low level of vitamin D correlated with disease activity in SLE 
patients, and circulating levels of activated vitamin D (1,25(OH)2D) contribute to VDR protein levels 
and its function. The objective of this study was to determine the correlation between vitamin D status 
with expression of VDR in peripheral blood mononuclear cell (PBMC) and the disease activity in SLE 
patients. The Research Subjects were 15 SLE patients (ACR 1997 criteria) from the Rheumato-
Immunology Division, dr. Saiful Anwar Hospital, Malang and 5 healthy controls. Serum vitamin D 
(25(OH)D3) level was assessed using ELISA method. VDR expression in PBMC was assessed using 
immunocytochemistry technique. The disease activity was measured by Systemic Lupus Erythematosus 
Disease Activity Index (SLEDAI) score. This study showed no difference on VDR expression in PBMC 
between patient and healthy control group, but patient with vitamin D deficiency had lower VDR 
expression in PBMC than the other group. No difference on SLEDAI score between the group. 
Vitamin D status correlated positively with VDR expression in PBMC (p < 0,035, r = 0,473). However 
vitamin D status did not correlate with disease activity scores (p = 0,686).  
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INTRODUCTION 
Autoimmune diseases are among the leading 
causes of death in young and middle-aged women 
in the United States [1]. In Indonesia, the number 
of people with Systemic Lupus Erythematosus 
(SLE) is not known precisely, estimated to 
number 1.5 million people [2]. SLE patients in 
Indonesia still have low of life expectancy, at 5 
years was 70% and 10 years by 55% [3]. Many 
studies reported an association between low 
levels of vitamin D to onset of autoimmune 
diseases including SLE [4].  
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These results are consistent with studies 
conducted in patients with SLE in Malang, 
Indonesia, which showed that the average of 
serum vitamin D levels were below normal (20.1 
+ 17.0 ng / ml), and was significantly lower than 
in healthy controls [5].  
Vitamin D is a steroid hormone with the 
effects on mineral metabolism, skeletal health, 
and recently known its effects on cardiovascular 
and immune health [6–8]. Low level of vitamin D 
is appears to be critical for autoimmune disease 
susceptibility and severity [9]. Many study 
demonstrated a negative correlation between 
25(OH)D and disease activity (SLEDAI score) 
among SLE patients [4,5]. In research Mok, et al, 
found that the levels of 25 (OH) D3 was 
negatively correlated with SLEDAI scores (β -
0.19, P = 0.003), due to kidney disease, 
hematologic and musculoskeletal more active 
[10]. 
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 The role of vitamin D in the regulation of 
immune responses mediated by the presence of the 
vitamin D receptor (VDR) in the activated 
inflammatory cells [11]. Some studies found 
circulating levels of activated vitamin D 
(1,25(OH)2D) contribute to VDR protein levels 
[4,12–14]. In a study in patients with pulmonary 
tuberculosis was reported that an increase in the 
level of 1,25-(OH)2D3, but the VDR protein levels 
decreased. Increased 1,25-(OH)2D3 may be 
possible to trigger the down regulation of VDR 
and will result low VDR signaling [15]. 
Vitamin D can be obtained from two sources, 
through diet or ultraviolet-mediated synthesis in 
the epidermal layer of skin. Two forms of vitamin 
D can be obtained from food, are vitamin D2 
(ergocalciferol) found in fungi / yeast, whereas 
vitamin D3 (cholecalciferol) contained in animal 
foods [16]. Ultraviolet rays trigger the breakdown 
of the photolysis of 7-dihydrocholesterol (7-DHC) 
into pre-vitamin D3, which will form the vitamin 
D3 through thermal isomerization process 
spontaneously [17].  
In terms of geographical location, Indonesia is 
at 6 ºNL (North latitude) and 11 ºLS (South 
latitude) and crossed the equator which indicates 
that Indonesia will be exposed to sunlight 
throughout the year, but according to a study 
reported that there were vitamin D deficiencies in 
females in all age groups in the Philippines, 
Malaysia, and Indonesia [4]. 
The role of vitamin D status on VDR and 
disease activity in Indonesian SLE patient remain 
unclear. Indonesia is one of tropical-climate 
country with nearly year-round excessive sun 
exposure, that supposed to be sufficient for 
vitamin D synthesis [4]. The objective of this study 
was to determine the correlation between vitamin 
D status with VDR expression in peripheral blood 
mononuclear cell (PBMC) and the disease activity 
in SLE patients. 
 
MATERIALS AND METHOD  
Study Subjects  
This research was carried out with the 
approval of the Ethical Board of Medical Faculty 
Brawijaya University, Malang, East Java, 
Indonesia. Written informed consent was 
obtained from all study participants. The subject 
were 15 female with SLE (ACR 1997 classification) 
[18,19] followed up at Rheumatology clinic or 
admitted to Internal Medicine Department ward at 
Saiful Anwar Malang Hospital. The patients were 
new onset of SLE / received treatment less than 6 
months, age between 18 years-premenopausal, 
pregnancy nor lactation, not using multi-vitamin 
supplement, able to speak and understand Indonesia 
language, and  able and willing to give informed 
consent. As the control group were 5 healthy age-
matched female. All subjects underwent history and 
physical examination and measurement of serum 
concentration of 25(OH)D3 and expression of 
vitamin D receptor. 
 
Assessment of Vitamin D Level 
Serum was obtained from subject’s blood sample; 
that were collected and stored in - 80°C.  The 
measurement of vitamin D (25(OH)D3) 
concentration was assayed using Enzyme-linked 
Immunosorbent Assay (ELISA) (Cusabio, Cat 
No.CSB-E08097h) in accordance with the 
manufacturer’s instruction. Vitamin D levels 
considered as normal when the concentration of 
25(OH)D3 were > 30 ng/ml; insufficiency (15-30 
ng/ml) and deficiency (<15 ng/ml). 
 
Isolation of Peripheral Blood Mononuclear Cells 
Peripheral blood mononuclear cells (PBMCs) were 
separated from whole blood of patients and healthy 
subjects that were collected in EDTA’s tube. The 
separation using standard Ficoll-Hypaque density 
gradient centrifugation. The separated cells were fixed 
on microscope slide using 100% methanol and stored 
at 4oC for immunocytochemistry examination [20]. 
 
Assessment of VDR Expression 
Expression of vitamin D receptor on peripheral 
mononuclear blood cell (PMBC) was assayed using 
immunocytochemistry method with specific polyclonal 
antibody to VDR (Novateinbio, Cat# SH-A16772), by 
examining the appearance of brown colour (DAB 
chromogen) under microscope light on 1000 x 
magnification.  
 
Assessment of SLE Activity 
Disease activity was measured with the 
Systemic Lupus Erythematosus Disease Activity 
Index (SLEDAI) using medical records, 
laboratory testing and personal interview and 
physical examination. This index consist of 24 
items with total score 0 – 105 [21]. All serological 
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marker were assayed in Central Laboratory of 
General Hospital dr. Saiful Anwar Malang, 
Indonesia. 
 
Statistical Analysis 
The differences between VDR expression 
levels of the SLE patients with normal vitamin D 
status, vitamin D insufficiency, vitamin D 
deficiency, and healthy control were analysed 
using one-way ANOVA, after tested its normality 
using Shapiro-Wilk. For data non-normally 
distributed, appropriate transformations were 
performed. Correlation between vitamin D status 
with VDR expression and disease activity were 
analysed using Spearman correlation test, 
whereas correlation between VDR expression 
and disease activity were analysed using Pearson 
correlation test. A p-value of <0.05 was 
considered significant. All calculations performed 
with the software of SPSS for Windows 16.0. 
 
RESULTS AND DISCUSSION 
In this study there was no difference on age 
and body mass index (BMI) between patient and 
healthy control group. Age of the sample was 30 
± 8,9 year for SLE patient and 33 ± 3,7 year for 
healthy control (mean ± SD). Body mass index 
(BMI) was 22,83 ± 5,1 for SLE patient and 19,16 
± 0,9 for healthy control (mean ± SD). High 
disease activity of SLE patient was found in 7 
patient (46,67%). The samples mean of age in 
this study was 30 ± 8,9 year, indicated that those 
were in productive ages. A study held on 2003 to 
2008 found that SLE incidence was 91,72% 
occurred between 18 – 64 years [22]. 
Result of this research showed that 53,3% 
SLE patient had normal body mass index, our 
result confirmed those of Attar, et al, [23] who 
also found that 30% of SLE patient had normal 
body mass index and 33% SLE patient had 
overweight and obesity (n = 95). The increasing 
of body mass index correlate with age, low social 
support,  and depression (OR 1.091, 95% confi-
dence interval 1.026-1.159, p = 0.005), but not 
correlate to disease activity, and patient quality of 
life [24].  
Low level of vitamin D is prevalent in SLE 
patient. Previous study showed that the average 
vitamin D level in SLE patients was below 
normal (20.1 + 17.0 ng/ml), and significantly 
lower in comparison to the healthy control [5]. 
Patients with SLE have multiple risk factors for 
25(OH)D deficiency. Photosensitivity, charac-
teristic of the disease, and the recommen-dation 
to apply  sunscreen are responsible for lower sun 
exposure, those factor contribute to the decrea-
sing of vitamin D production in the skin [25]. 
One of reasons of why hypovitaminosis D can 
be a cause of SLE is the presence of evidence 
that vitamin D has a role in the regulation of the 
immune system that prevents autoimmunity. 
Vitamin D receptor that is expressed in various 
cells in the immune system [26], 1,25(OH)2D3 
can regulate the activity of T cells either directly 
or indirectly through modulation of APC func-
tion [27] and 1,25(OH)2D3 directly suppress the 
code transcription process of cytokine genes 
associated with Th1 [28].  
Positive VDR expression in PBMC was seen 
in patient and healthy control (expressed in 
brown color) and the number of cell expressed 
VDR was differ between group. We found no 
difference of VDR expression in PBMC between 
      
 
 Table 1. VDR expression and SLEDAI score in healthy control and patient with SLE based on vitamin D status 
 
Subject Vitamin D level 
(ng/ml) 
(mean ± SD) 
VDR expression (%) 
(mean ± SD) 
SLEDAI score 
(mean ± SD) 
Healthy control (n= 5) 37,5 ± 4,0 42,49 ± 9,1 - 
Patient with SLE    
   Normal Vitamin D (n= 5) 36,0 ± 5,9 45,59 ± 1,5 11,2 ± 6,6 
   Vitamin D insufficiency (n= 5) 23,5 ± 2,7 37,56 ± 1,8 8,6 ± 4,7 
   Vitamin D deficiency (n= 5) 13,8 ± 6,0 28,85 ± 1,9 12,8 ± 4,6 
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patient and healthy control group however 
patient with vitamin D deficiency tend to have 
lower VDR expression than the other group 
(Table 1). Patients with low level of vitamin D 
tended to have lower VDR expression compared 
to patient and healthy control with normal 
vitamin D status. This result confirmed to 
Ogunkolade, et al, that circulating levels of 
activated vitamin D (1,25(OH)2D) to contribute 
to VDR protein levels [12]. 
Vitamin D receptor is found in abundant 
concentrations in the T lymphocyte and  
macrophage, and the highest concentration is in 
the immature immune cells of the thymus and the 
mature CD-8 T lymphocytes [30]. A clinical study 
reported that 76% seropositive patients with 
rheumatoid arthritis had lymphocytes that 
possessed VDR (without in vitro activation) 
compared to only 18% (3 of 17) in normal 
individuals [31]. 
Our study showed that vitamin D status 
positively correlated with VDR expression (p = 
0,035; r = 0,473). It has been demonstrated that 
1,25-(OH)2D3 stabilizes the receptor when 
bound each other and 1,25-(OH)2D3 prevents 
inactivation of its receptor during purification 
[32]. This could be due to 1,25-(OH)2D3 
protected its receptor from proteolytic attack 
from endogenous proteases present in the 
extracts. These enzymes may also function in 
intact cells [32]. 
Disease activity score in SLE patient with 
vitamin D deficiency ranged from 8 to 18, in SLE 
patients with vitamin D insufficiency ranged 
from 2 to 14, the disease activity in SLE patient 
with normal vitamin D status ranged from 4 to 
18. We found no significant correlation between 
vitamin D status and disease activity scores group  
(p = 0,483). However we found that the patient 
with vitamin D deficiency tend to have higher  
SLEDAI scores than others, even there is no 
significant difference between group. Confirmed 
to Mok et al., we found that 25(OH)D3 level 
negatively correlated with SLEDAI scores (β -
0.19; P = 0.003), due to more active renal disease, 
musculoskeletal and hematologic disease.  
The study suggested that low level of 
25(OH)D3 be correlated with B cell hyperactivity 
and increased autoantibodies production, but not 
related to complement activation [10]. Previous 
studies have yielded conflicting evidence for a 
relationship between 25-hydroxyvitamin D3 level 
and SLE disease activity. The result is attributed 
to many factors, such as inadequate sample size, 
seasonal variation of vitamin D levels, and the 
small proportion of participants with active SLE 
recruited into the research [33].  
We found that the SLEDAI score did not 
correlate with VDR expression, but patient with 
lower VDR expression seemed to have higher 
SLEDAI score. TB patient significantly had 
lower VDR protein than the healthy control. The 
decreasing of VDR protein in TB patient might 
be due to VDR expression down-regulation as a 
result from increasing of 1,25(OH)2D3 synthesis 
[15, 34]. The decrease might lead to defective 
VDR signalling due to the unavailibity of 
receptors for 1,25(OH)2D3. Defective VDR 
signalling might result in the increased 
inflammation due to the increased expression of 
inflammatory cytokines [15]. 
 
CONCLUSIONS 
 
Vitamin D status significantly correlated with 
VDR expression in PBMC, and VDR expression 
in PBMC did not correlate with disease activity 
scores. A limitation of this study was in its 
sample size. This research indicates that the 
vitamin D and its receptor played a role in 
autoimmune disease, especially in SLE.  
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